Related LncRNAs |
ID |
lncRNA Name |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
EL0578 |
HOTAIR |
diffuse large B-cell lymphoma |
The reverse transcription‑polymerase chain reaction & Western blotting |
N/A |
up-regulated |
N/A |
HOTAIR was significantly correlated with tumor size, clinical stage, B symptoms and International Prognostic Index scores |
27122348 |
|
EL0600 |
HULC |
diffuse large B-cell lymphoma |
in a cohort of DLBCL |
DLBCL tissues and cell lines |
up-regulated |
N/A |
HULC was closely related to DLBCL characteristics |
27044827 |
|
EL0850 |
LUNAR1 |
diffuse large B-cell lymphoma |
Quantitative real-time PCR, knockdown |
Diffuse large B-cell lymphoma (DLBCL) tissues and cell lines |
N/A |
interaction |
The higher expression of LUNAR1 was significantly correlated with stage, rituximab and IPI. Univariate and multivariate analyses showed that LUNAR1 expression served as an independent predictor for overall survival and progression-free survival. LUNAR1 may serve as a candidate prognostic biomarker through growth regulation in DLBCL. |
26796267 |
|
EL0878 |
MIR17HG |
diffuse large B-cell lymphoma |
qPCR, Northern blot etc. |
cell lines (OCI-Ly4, OCI-Ly7, OCI-ly8 etc.) |
up-regulated |
locus |
C13orf25 (MIR17HG) is a target for 13q31-q32 amplification in malignant lymphoma. |
15126345 |
LncRNADisease Lnc2Cancer
|
EL1063 |
PEG10 |
diffuse large B-cell lymphoma |
qPCR, knockdown etc. |
DLBCL tissue, cell lines (OCI-LY-3, OCI-LY-7, OCI-LY-10 etc.) |
up-regulated |
expression |
We first found that the expression of PEG10 was upregulated in DLBCL tumorous tissues and that cell lines compared with the normal. Moreover, we illustrated that PEG10 was significantly correlated with B symptoms, IPI score, CHOP-like treatment and rituximab. |
25864113 |
Lnc2Cancer
|
|